Ender Terzıoğlu

1.6k total citations
54 papers, 1.2k citations indexed

About

Ender Terzıoğlu is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, Ender Terzıoğlu has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 9 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Ender Terzıoğlu's work include T-cell and B-cell Immunology (6 papers), Allergic Rhinitis and Sensitization (5 papers) and Immunotherapy and Immune Responses (5 papers). Ender Terzıoğlu is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Allergic Rhinitis and Sensitization (5 papers) and Immunotherapy and Immune Responses (5 papers). Ender Terzıoğlu collaborates with scholars based in Türkiye, Canada and United States. Ender Terzıoğlu's co-authors include Veli Yazısız, Funda Erbasan, Rüçhan Uslu, Bülent Karabulut, Canfeza Sezgin, Erdem Göker, Fehmi Akçiçek, Güray Saydam, Filiz Sebik and Serdar Bedii Omay and has published in prestigious journals such as Poultry Science, Nephrology Dialysis Transplantation and Lara D. Veeken.

In The Last Decade

Ender Terzıoğlu

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ender Terzıoğlu Türkiye 20 359 210 198 180 156 54 1.2k
Stéphane Jaisson France 27 539 1.5× 229 1.1× 109 0.6× 184 1.0× 114 0.7× 72 1.7k
Valery Leytin Canada 21 436 1.2× 137 0.7× 259 1.3× 217 1.2× 261 1.7× 49 1.8k
H.J.M. van Rijn Netherlands 22 349 1.0× 284 1.4× 105 0.5× 316 1.8× 287 1.8× 59 1.5k
Kateřina Kaňková Czechia 21 312 0.9× 121 0.6× 135 0.7× 99 0.6× 58 0.4× 78 1.2k
Stavros Topouzis Greece 19 761 2.1× 291 1.4× 151 0.8× 141 0.8× 154 1.0× 32 1.6k
Akira Furusu Japan 23 482 1.3× 106 0.5× 262 1.3× 186 1.0× 73 0.5× 59 1.4k
Marilena Formato Italy 20 304 0.8× 95 0.5× 146 0.7× 250 1.4× 129 0.8× 59 1.1k
P Lohse Germany 27 586 1.6× 140 0.7× 270 1.4× 450 2.5× 176 1.1× 57 1.4k
Jung Hye Kim South Korea 17 459 1.3× 290 1.4× 122 0.6× 162 0.9× 189 1.2× 37 1.3k
Detlef Lang Germany 21 462 1.3× 87 0.4× 219 1.1× 150 0.8× 108 0.7× 40 1.5k

Countries citing papers authored by Ender Terzıoğlu

Since Specialization
Citations

This map shows the geographic impact of Ender Terzıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ender Terzıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ender Terzıoğlu more than expected).

Fields of papers citing papers by Ender Terzıoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ender Terzıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ender Terzıoğlu. The network helps show where Ender Terzıoğlu may publish in the future.

Co-authorship network of co-authors of Ender Terzıoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Ender Terzıoğlu. A scholar is included among the top collaborators of Ender Terzıoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ender Terzıoğlu. Ender Terzıoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hamuryudan, Vedat, Haner Di̇reskeneli̇, İhsan Ertenli, et al.. (2017). Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey.. PubMed. 34(6). 1033–1037. 9 indexed citations
3.
Yalçın, Arzu Didem, et al.. (2011). Occupational disease of healthcare workers: latex allergy.. 33(2). 103–110. 4 indexed citations
4.
Bişgin, Atıl, Ender Terzıoğlu, Çiğdem Aydın, et al.. (2010). TRAIL Death Receptor-4, Decoy Receptor-1 and Decoy Receptor-2 Expression on CD8+ T Cells Correlate with the Disease Severity in Patients with Rheumatoid Arthritis. BMC Musculoskeletal Disorders. 11(1). 192–192. 21 indexed citations
5.
Terzıoğlu, Ender, et al.. (2009). The Employment Problems And New Job Opportunities Of Persons Graduated From Physical Education And Sports Area. Erzincan Üniversitesi Eğitim Fakültesi Dergisi. 11(2). 99–118. 3 indexed citations
7.
Yazısız, Veli, et al.. (2009). CTLA‐4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients. International Journal of Immunogenetics. 36(4). 245–250. 22 indexed citations
8.
Yazısız, Veli, et al.. (2009). A case of primary Sjögren’s syndrome with pulmonary-limited Wegener’s granulomatosis. Rheumatology International. 30(9). 1235–1238. 7 indexed citations
9.
Yazısız, Veli, et al.. (2008). Diagnostic performance of minor salivary gland biopsy, serological and clinical data in Sjögren’s syndrome: a retrospective analysis. Rheumatology International. 29(4). 403–409. 23 indexed citations
10.
Tunç, Şevket Ercan, Kenan Aksu, Gökhan Keser, et al.. (2004). Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet’s patients. Rheumatology International. 25(5). 326–331. 20 indexed citations
11.
Çoban, Erkan & Ender Terzıoğlu. (2004). A patient with hyper-IgD syndrome in Antalya, Turkey. Clinical Rheumatology. 23(2). 177–178. 8 indexed citations
12.
Saydam, Güray, et al.. (2002). Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation. Leukemia Research. 26(4). 391–398. 21 indexed citations
13.
Saydam, Güray, Hikmet Hakan Aydın, Fahri Şahin, et al.. (2002). Cytotoxic and inhibitory effects of 4,4′-dihydroxy chalcone (RVC-588) on proliferation of human leukemic HL-60 cells. Leukemia Research. 27(1). 57–64. 47 indexed citations
14.
Erensoy, Selda, et al.. (2000). The investigation of the response to antiretroviral therapy with viral load and CD4+ cell count.. 14(3). 343–347. 1 indexed citations
15.
Terzıoğlu, Ender, Ali Kokuludağ, Aytül Sin, et al.. (1998). Selective IgA deficiency and ankylosing spondylitis.. PubMed. 7(6). 619–20. 2 indexed citations
16.
Gorczynski, Reginald M., et al.. (1997). An antibody specific for interleukin‐6 reverses age‐associated changes in spontaneous and induced cytokine production in mice. Immunology. 92(1). 20–25. 19 indexed citations
17.
Nalbantgil, İstemi, et al.. (1996). The Efficacy of Felodipine ER on Regression of Left Ventricular Hypertrophy in Patients with Primary Hypertension. Blood Pressure. 5(5). 285–291. 6 indexed citations
18.
Terzıoğlu, Ender, et al.. (1996). Altered serum cytokines in hepatic and portal blood of rats at early times following portal venous infusion of semi-allogeneic cells. Immunology Letters. 49(1-2). 31–36. 2 indexed citations
19.
Nalbantgil, İstemi, et al.. (1993). The Effect of Age and Sex on White-coat Hypertension. Archives of the Turkish Society of Cardiology. 21(3). 182–183. 1 indexed citations
20.
Kumral, Emre, Mehmet İşler, Ender Terzıoğlu, & Hasan Yılmaz. (1990). Electrocardiographic Findings in Hemorrhagic Stroke: Subarachnoid Hemorrhage. Archives of the Turkish Society of Cardiology. 18(1). 35–38. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026